Trend Press Wire

Self-monitoring Blood Glucose Devices Market is Heading Up 5 Bn US$ By 2026

Press release   •   Aug 08, 2019 05:41 EDT

According to Acumen Research and Consulting, The global Self-monitoring Blood Glucose Devices Market Size is anticipated to around US$ 19 billion by 2026. The market is anticipated to grow at a CAGR of 5% from 2019 to 2026.

Diabetes is a clinical disorder in which the amount of glucose in blood rises owing to pancreas inefficiency in insulin production. The management of diabetes is used to regulate blood sugar concentrations that can be tracked by blood glucose meters. Blood glucose instruments are self-monitored to track blood glucose concentrations in diabetic clients and monitor them.

The self-monitoring industry for blood glucose instruments is expected to grow in the short term, due to variables such as an increase in the incidence of diabetes, an increase in the diabetes susceptible population, technological advances in the use of diabetes machines and an increase in the need for quicker and safer diagnosis and diabetes treatment. However, blood glucose monitors do not evaluate the precise blood sugar amount, and measurements are given in a certain spectrum. Furthermore, the adverse effects of some of the diabetes treatments hinder market growth. A greater knowledge of diabetes surveillance equipment and untapped market possibilities in emerging areas should offer countless market growth possibilities.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1552

The test strip industry accounted for approximately 80% of the biggest share of revenues in 2018. Similar trend is expected for the prediction era. Test rolls are an important component of the sugar meters. Therefore, elevated acceptance and expense for test strips by patients with diabetes will increase segmental development. For example, about 90 percent of UK nurses use blood sugar meter with test strips with an approximate projected annual expenditure of approximately USD 974. In addition, advances in test strips such as the Solo meter, which includes four test strips, help to provide rapid, more accurate test results. Such innovations, combined with the accessibility of cheap test strips, will increase market growth in test strips during the projection era.

The market for Continuous Glucose Monitors (CGMs) is estimated at more than 5% CAGR in the analytical timeline. CGMs are usually used by physicians requiring frequent surveillance of blood glucose. CGM models assist forecast potential occurrences for up to 60 minutes in hypoglycaemia or hyperglycaemia and provide clinically appropriate data on glucose trends. The advantages of ongoing glucose monitoring in geriatric or critical patients will stimulate segmental development over the next few years.

North America accounted for more than two-fifths of the world market share in 2018. The prediction era is anticipated to stay dominant. This is due to the rise in cancer incidence, development of the geriatric population and the acceptance of the sedentary lifestyle of diabetes-causing individuals. Furthermore, the elevated pace of acceptance of technologically advanced appliances and the existence of advanced healthcare infrastructure are anticipated to give the market players fresh possibilities for development.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/self-monitoring-blood-glucose-devices-market

Key Players & Strategies

Among the main competitors Dexcom, Roche, Abbott Laboratories, Johnson & Johnson and Medtronic are among the most prominent competitors competing in the worldwide blood sugar monitoring industry. These companies ' key policies include purchases, merger, partnerships and brand developments & launch to consolidate their customer base and grow company globally.

In January 2019 Medtronic, in cooperation with Eris Lifesciences, announced the introduction of its first Smart Continuous Glucose Monitoring System (CGMS) in India. The implementation aims to achieve a bigger client base in India with its sophisticated technological tool.

In July 2018 Abbott was approved for the Libre Flash glucose surveillance scheme FreeStyle that makes the unit the most durable private insulin detector and is accessible prescribed for use. The endorsement will improve the company's brand base and achieve competitive edge.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Self-Monitoring Blood Glucose Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Self-Monitoring Blood Glucose Devices Market By Product
1.2.2.1. Global Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Self-Monitoring Blood Glucose Devices Market Revenue Share By Product in 2017
1.2.2.3. Continuous Glucose Monitors
1.2.2.4. Lancets
1.2.2.5. Self-monitoring Blood Glucose Meters
1.2.2.6. Testing Strips
1.2.2.7. Others
1.2.3. Self-Monitoring Blood Glucose Devices Market By Application
1.2.3.1. Global Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Type 2 Diabetes
1.2.3.3. Type 1 Diabetes
1.2.3.4. Gestational Diabetes
1.2.3.5. Others
1.2.4. Self-Monitoring Blood Glucose Devices Market By End Users
1.2.4.1. Global Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Home Usage
1.2.4.3. Hospitals
1.2.4.4. Diagnostic Clinics & Centers
1.2.5. Self-Monitoring Blood Glucose Devices Market by Geography
1.2.5.1. Global Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Self-Monitoring Blood Glucose Devices Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Self-Monitoring Blood Glucose Devices Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Self-Monitoring Blood Glucose Devices Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Self-Monitoring Blood Glucose Devices Major Manufacturers in 2017

CHAPTER 4. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY PRODUCT
4.1. Global Self-Monitoring Blood Glucose Devices Revenue By Product
4.2. Continuous Glucose Monitors
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Lancets
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Self-monitoring Blood Glucose Meters
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Testing Strips
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY APPLICATION
5.1. Global Self-Monitoring Blood Glucose Devices Revenue By Application
5.2. Type 2 Diabetes
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Type 1 Diabetes
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Gestational Diabetes
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY END USERS
6.1. Global Self-Monitoring Blood Glucose Devices Revenue By End Users
6.2. Home Usage
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Diagnostic Clinics & Centers
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY COUNTRY
7.1. North America Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Self-Monitoring Blood Glucose Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Self-Monitoring Blood Glucose Devices Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY COUNTRY
8.1. Europe Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Self-Monitoring Blood Glucose Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Self-Monitoring Blood Glucose Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY COUNTRY
10.1. Latin America Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Self-Monitoring Blood Glucose Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY COUNTRY
11.1. Middle East Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Self-Monitoring Blood Glucose Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET BY COUNTRY
12.1. Africa Self-Monitoring Blood Glucose Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Self-Monitoring Blood Glucose Devices Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Dexcom
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Roche
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Abbott Laboratories
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Johnson & Johnson
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Medtronic
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Others
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1552

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1552